Stay updated on Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/software version change rather than any change to the trial information displayed.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:51:21.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added AA amyloidosis and multiple myeloma as related disease terms and included the Genetic and Rare Diseases Information Center as a resource.
    Difference
    0.2%
    Check dated 2026-04-03T05:47:06.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:49:02.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:26.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2; no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:01:47.000Z thumbnail image

Stay in the know with updates to Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.